At BD, we’re fortunate to work alongside some of the best and brightest in med tech. We’re thrilled that two of our outstanding associates will be recognized for their leadership in the healthcare industry by the Healthcare Businesswoman’s Association (HBA) at the organization’s annual Women of the Year event on May 10.
Stephanie Klocke, VP of Research and Development for BD Interventional—Peripheral Intervention, will receive the HBA Luminary award. Lucy Turland, Associate Director in the US Region for BD Life Sciences—Integrated Diagnostic Systems, will be recognized as an HBA Rising Star.
“Congratulations to Stephanie and Lucy for the well-deserved recognitions of both professional achievements and their commitment to fostering an inclusive workplace,” said Nicole Thompson, Vice President, Inclusion & Diversity, BD. “They embody a servant leadership philosophy centered around empowering associates throughout the organization and have truly embraced a growth mindset turning obstacles and challenges throughout the COVID-19 pandemic into opportunities.
HBA is a global nonprofit organization comprised of individuals and organizations from across the healthcare industry committed to achieving gender parity in leadership positions; facilitating career and business connections; and providing effective practices that enable organizations to realize the full potential of their female talent. Its annual Women of the Year event celebrates wins of the industry and individual achievements, in addition to providing networking opportunities. Here's a closer look at each HBA award and honoree:
Stephanie Klocke – HBA Luminary Award
We’re proud to celebrate Stephanie for the HBA Luminary Award. This award honors professionals with more than 20 years of professional industry experience, who serve as role models in their company, actively mentor and sponsor others, and are shining examples of transformational leadership.
“It was a surprise to hear that I was nominated, let alone won,” said Stephanie. “Anything that I’ve been a part of accomplishing has been a result of the incredible team that I’m surrounded by both within R&D and by all of those across the company who I’m lucky to get to work with.”
In her role, Stephanie is responsible for overseeing the new product development pipeline for three key platforms including peripheral arterial disease, end stage kidney disease and oncology. Stephanie has launched an incredibly impressive 56 products that have generated more than $1B in revenue in less than five years. As a leader of more than 250 associates across five design centers around the world, Stephanie has been integral to amplifying our culture of innovation.
“Steph is a results-orientated, innovative, and strategic leader with expertise in the development and implementation of strategies to maximize businesses current and future portfolio and success,” said Kevin Boyle, SVP R&D Interventional Segment. “She has a proven ability to motivate teams that work cohesively with internal and external partners to achieve common organizational goals.”
Stephanie is passionate about mentorship and advancing talent, driving her teams to be proactive with training, promotions and broadening their work experience. She is also dedicated to promoting inclusion throughout the organization and the industry and serves on the BD Global Inclusion Council as the R&D lead for ID&E.
Outside of BD, Stephanie serves on the Cardiovascular Implant Durability (CVID) advisory committee.
Lucy Turland – HBA Rising Star
We are proud to recognize Lucy Turland as the HBA Rising Star. This award recognizes professionals in the early stages of their career for outstanding performance, commitment to excellence and valuable contributions to their companies’ success. The Rising Stars are inspiring leaders, role models to others and celebrated for their vision, dedication, and action.
“When I was told, I couldn’t really speak, I was so surprised,” said Lucy. “There are so many great women deserving of this accolade, and I feel truly honored to be considered within the category. It’s real moment that I’ll look back on and be forever grateful for.”
Lucy has done a tremendous job leading the point of care COVID-19 strategy through a year of unprecedented challenges—including navigating COVID-19 surges amid supply chain obstacles, leading the successful launch a new combined assay, creating sustainable opportunities for growth and helping BD Integrated Diagnostic Solutions to achieve $1B+ revenue in the first year of commercialization for the point-of-care professional COVID solution.
“As a manager, I have rarely met an individual working for a business and a company that is more passionate, more inspiring, and harder working than Lucy,” said Diana Kroeber, Director of Marketing, Point of Care. “Lucy has worked day and night to serve the customer, provide a positive customer experience, and present BD in the upmost positive way. Time in time again, she has rolled up her sleeves, inspired numerous cross-functional team members and lead the team to fulfill the task at hand.” Diana cited her agility, positive attitude, organizational and communications skills, and ability to stay calm under pressure as invaluable to BD.
Lucy has also long been involved with the Women’s Initiative Network (WIN) at BD, helping to champion transparency around inclusion and advancement at the regional, chapter and global level. She now serves as Global WIN Co-Lead and had demonstrated her leadership with significant contributions, including co-leading the launch of the global mentoring program and co-leading the Development and Advancement Pillar to drive strategic rigor into this critical workstream.
HBA will announce the Rising Stars and Luminaries on March 22nd through their website and social media campaigns and present the honorees with awards at the HBA Women of the Year event in New York City on May 10, 2022. To learn more visit hbanet.org
Subscribe to receive BD blog alerts